MyBlueDotsCytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs MyBlueDots5 months ago01 mins OKLAHOMA CITY & TORRANCE, Calif.–(BUSINESS WIRE)–This new collaboration provides a scalable, integrated solution for developing and manufacturing complex peptide drugs efficiently. Go to Source Author: Post navigation Previous: BioBam Presents OmicsBox 3.4, Including CellKB’s Advanced Cell-Type AnnotationNext: Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
Neighborly help in the brain: Cerebral cortex networks rapidly reorganize to compensate for lost neurons MyBlueDots13 hours ago 0
FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression MyBlueDots19 hours ago 0
US measles count nears 1,200 cases as Ohio officials confirm 3 outbreaks are over MyBlueDots19 hours ago 0
2020 to 2022 saw nearly 2 million annual emergency room visits for dental issues MyBlueDots1 day ago 0